(OMI) Owens Minor - Ratings and Ratios

Owens & Minor, Inc. (NYSE:OMI) is a global healthcare solutions provider operating through two primary segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment delivers a comprehensive portfolio of medical and surgical supplies, including both branded and proprietary products. It also offers specialized services such as supplier management, analytics, inventory management, and clinical supply management. Additionally, this segment provides outsourced logistics and marketing solutions to suppliers, enhancing operational efficiency for its partners. The Patient Direct segment focuses on in-home care, offering products and services for diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. It also supplies a range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions. The company serves a diverse customer base, including multi-facility healthcare networks, independent hospitals, surgery centers, and physicians practices, both directly and through third-party distributors. Owens & Minor, founded in 1882 and headquartered in Mechanicsville, Virginia, has established itself as a key player in the healthcare distribution and services industry.

From a technical perspective, Owens & Minors stock is currently trading at $6.89, below its 20-day SMA of $8.37, 50-day SMA of $11.64, and 200-day SMA of $14.17. This indicates a bearish trend in the near term. The Average True Range (ATR) of 0.67 suggests moderate volatility. On the fundamental side, the company has a market cap of $479.62 million, with a forward P/E ratio of 3.37, indicating potential undervaluation. However, the current P/E ratio is 0.00, reflecting no earnings per share. The price-to-book (P/B) ratio of 0.55 and price-to-sales (P/S) ratio of 0.05 suggest undervaluation relative to book value and revenue. The return on equity (RoE) of -5.58% highlights current profitability challenges.